Liquidia Announces Pricing of Public Offering of Common Stock Nasdaq:LQDA


RESEARCH TRIANGLE PARK, N.C., June 29, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT® technology, announced the pricing of an underwritten public offering of 9,375,000 shares of its common stock at a public offering price of $8.00, for total gross proceeds of $75 million, before deducting underwriting discounts and commissions and expenses payable by Liquidia. All of the shares in the offering will be sold by Liquidia. In addition, Liquidia has granted the underwriters a 30-day option to purchase up to an additional 1,406,250 shares of common stock at the public offering price, less the underwriting discount and commissions. The offering is expected to close on July 2, 2020, subject to customary closing conditions. 

Jefferies is acting as the sole book-running manager for the offering. Needham & Company and Wedbush PacGrow are acting…

Click here for the full story.

Tim Tam maker Arnott’s loses 50 jobs in first cuts since KKR buyout By Reuters

Previous article

Wirecard scandal casts a shadow on governance

Next article

You may also like

Leave a Reply

Notify of

More in Earnings